Norton Rose Fulbright is renowned for its proficiency in pharmaceutical product liability cases and spin-off economic loss litigations. Dallas-based practice head D’Lesli Davis is vastly experienced leading high-stakes litigation in some the country’s most difficult jurisdictions; indeed, she is a key figure in the firm’s representation of Takeda as lead counsel in a national RICO economic loss putative class action arising from allegations of the company’s failure to warn of side effects, pending in Los Angeles federal court. Along with Houston’s Ellie Norris, Davis also represents McKesson Corporation in the Sartan MDL. New joiner Josh Lee arrived from Riley Safer Holmes & Cancila to co-head the litigation and disputes practice from Chicago.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Takeda Pharmaceutical Company
- McKesson Corporation
Highlight-Mandate
- Representing Takeda Pharmaceuticals as lead counsel in a national RICO economic loss putative class action arising from allegations of failure to warn of side effects.
- Representing Takeda Pharmaceuticals and Abbott in the PPI (Prevacid, Prilosec) personal injury MDL within a virtual law firm.
- Representing pharmaceutical wholesaler McKesson Corporation in the 3-pronged Sartan (blood pressure pharmaceuticals valsartan, losartan and irbesartan) MDL.
Anwält*innen
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Praxisleitung
D’Lesli Davis
Weitere Kernanwält*innen
Ellie N0rris; Josh Lee; Geraldine Young; Alicia Grant